Findings could help researchers develop new treatments for the most devastating forms of multiple sclerosis and other demyelinated diseases.
Researchers successfully used a synthetic compound to stimulate a receptor pathway to promote remyelination in the brain. The technique may have significant beneficial implications for treating multiple sclerosis, researchers say.
Researchers discover the axons of auditory neurons which respond to low and high frequency sounds differ in morphology. These variations correlate with differences in the speed of signal conduction.
A new study outlines the mechanism involved in remyelination.
Myelin thickness and oligodendrocytes were significantly reduced in the prefrontal cortex in mouse models of Williams syndrome.
Melanocyte stem cells from human hair follicles that carry CD34 have the ability to turn into glial cells. The CD34+ stem cells can regenerate myelin, both on neurons and in mouse models with a genetic defect that prevents the formation of healthy myelin sheaths. The findings could have positive implications for the treatment of demyelinating diseases, such as Multiple Sclerosis.
